1Leon S,Robert H,Glass N,et al.Clinical gynecologic endocrinology and infertility[M].USA:Published by Arrangement With Lippincott Williams and Wilkins Inc,2001:113-126
2Carmina E.Genetic and environmental aspect of polycystic ovary syndrome[J].J Endocrinol Invest,2003,26 (11):1151-1159.
3Bachner-Melman R,Zohar AH,Nemanor L,et al.Association between the insulin-like growth factor 2 gene (IGF-2) and scores on the eating attitudes test in nonclinical subjects:a family-based study[J].Am J Psychiatry,2005,163(12):2256-2262.
4Anisman H,Kelly O,Hayley S,et al.Acoustic startle and fear potentiated startle in rats selectively bred for fast and slow kindling rates:relation to monoamine activity[J].Eur J Nenrosci,2000,12(12):4405-4416.
5Orteqa-Gonzalez C,Cardoza L,Coutino B,et al.Insulin sensitizing drugs increase the endogenous dopaminergic tone in obese insulin-resistant women with polycystic ovary syndrome[J].J Endocrinol,2005,184(1):233-239.
6Tsatsoulis A,Fountoulakis S.The protective role of exercise on stress system dysregulation and comorbidities[J].Ann N Y Acad Sci,2006,1083(11):196-213.
7Dominici FP,Turyn D.Growth hormone-induced alterations in the insulin signaling.system[J].Exp Biol Med (Maywood),2002,227 (3):149-157.
8Hashimoto S,Yatabe JI,Midorikawa S,et al.Inhibition of growth hormone excess reduces insulin resistance and ovarian dysfunction in a lean case of polycystic ovary syndrome with a growth-hormone-producing pituitary adenoma[J].Horm Res,2003,59 (3):149-155.
10Tomei F,Ciarrocca M,Cherubini E,et al.Prolactin levels in workers exposed to chemical,physical and psycho-social urban stressors[J].J Occup Health,2006,48(4):253-260.
二级参考文献8
1Coffey S, Mason H. The effect of polycystic ovary syndrom on health related quality of life. Gynecol Endocrinol,2003;17(5):379～86.
2Elsenbruch S, Hahn S, Kowalsky D et al. Quality of life psychosocial well-being, and sexual satisfaction in women with polycystic ovary syndrome. J Clin Endocrinol Metab,2003;88(12):5801～7.
3Eggers S, Kirchengast S. The polycystic ovary syndrome a medical condition but also an important psychosocial problem. Coll Antropol, 2001; 25(2):673～85.
4Pellieux C, Sauthier T, Domenighetti A et al. Neuropeptide Y (NPY) potentiates phenylephrine-induced mitogen-activated protein kinase activation in pprimary cardiomyocytes via NPY Y5 receptors.Proc Natl Acad Sci USA, 2000;97(4):1595～600.
5Thorsell A, Michalkiewicz M, Dumont Y et al. Behavioral insensitivity to restraint stress, absent fear suppression of behavior and impaired spatial learning in transgenic rats with hippocampal neuropeptide Y overexpression. Proc Natl Acad Sci USA, 2000;97(23):12852～7.
6Morgan CA, Rasmusson AM, Wang S et al. Neuropeptide-Y, cortisol, and subjective distress in human exposed to acute stress: replication and extension of pevious report. Biol Psychiatry, 2002;52(2):136～42.
7Moran C, Azziz R. The role of the adrenal cortex in polycystic ovary syndrome. Obstet Gyneclo Clin North Am, 2001;28(1):63～75.
